BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eder AF, Manno CS. Does red-cell T activation matter?: Annotation. British Journal of Haematology 2001;114:25-30. [DOI: 10.1046/j.1365-2141.2001.02886.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Chan Y, Chang F, Wang C, Lin M. Thomsen-Friedenreich activation in infants with necrotizing enterocolitis in Taiwan: T ACTIVATION IN NECROTIZING ENTEROCOLITIS. Transfusion 2011;51:1972-6. [DOI: 10.1111/j.1537-2995.2011.03106.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Scobell RR, Kaplan BS, Copelovitch L. New insights into the pathogenesis of Streptococcus pneumoniae–associated hemolytic uremic syndrome. Pediatr Nephrol 2020;35:1585-91. [DOI: 10.1007/s00467-019-04342-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Prestidge C, Wong W. Ten years of pneumococcal-associated haemolytic uraemic syndrome in New Zealand children. Journal of Paediatrics and Child Health 2009;45:731-5. [DOI: 10.1111/j.1440-1754.2009.01603.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
4 Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB; European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 2006;70:423-31. [PMID: 16775594 DOI: 10.1038/sj.ki.5001581] [Cited by in Crossref: 199] [Cited by in F6Publishing: 144] [Article Influence: 12.4] [Reference Citation Analysis]
5 Spence RK. Clinical use of plasma and plasma fractions. Best Practice & Research Clinical Haematology 2006;19:83-96. [DOI: 10.1016/j.beha.2005.01.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
6 Roseff SD. Cryptantigens: time to uncover the real significance of T-activation: EDITORIAL. Transfusion 2017;57:2553-7. [DOI: 10.1111/trf.14366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Johnson S, Taylor CM. Hemolytic Uremic Syndrome. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric Nephrology. Berlin: Springer Berlin Heidelberg; 2009. pp. 1155-80. [DOI: 10.1007/978-3-540-76341-3_48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 . Transfusion guidelines for neonates and older children: Guideline. British Journal of Haematology 2004;124:433-53. [DOI: 10.1111/j.1365-2141.2004.04815.x] [Cited by in Crossref: 244] [Cited by in F6Publishing: 170] [Article Influence: 13.6] [Reference Citation Analysis]
9 Burin des Roziers N, Chadebech P, Bodivit G, Guinchard E, Bruneel A, Dupré T, Chevret L, Jugie M, Gallon P, Bierling P, Noizat-Pirenne F. Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia.Transfusion. 2015;55:1563-1571. [PMID: 25556575 DOI: 10.1111/trf.12981] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
10 Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol 2014;36:399-420. [PMID: 24526222 DOI: 10.1007/s00281-014-0416-x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 67] [Article Influence: 11.5] [Reference Citation Analysis]
11 Bitzan M, Lapeyraque A. Postinfectious Hemolytic Uremic Syndrome. In: Geary DF, Schaefer F, editors. Pediatric Kidney Disease. Berlin: Springer Berlin Heidelberg; 2016. pp. 653-731. [DOI: 10.1007/978-3-662-52972-0_26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
12 Yamada C, Davenport RD. A case of extravascular hemolysis with Tk-activation. Clin Case Rep 2014;2:137-42. [PMID: 25356271 DOI: 10.1002/ccr3.80] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Oliver JW, Akins RS, Bibens MK, Dunn DM. Pneumococcal Induced T-activation with Resultant Thrombotic Microangiopathy. Clin Med Insights Pathol 2010;3:13-7. [PMID: 21151550 DOI: 10.4137/cpath.s670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
14 Boralessa H, Modi N, Cockburn H, Malde R, Edwards M, Roberts I, Letsky E. RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice. Transfusion 2002;42:1428-34. [PMID: 12421215 DOI: 10.1046/j.1537-2995.2002.00237.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
15 des Roziers NB, Bodivit G, Chadebech P, Nzouakou R, Bierling P, Noizat-pirenne F. Anti-T haemolysins: the effects of sialic acid removal and 2-aminoethylisothiouronium bromide treatment of erythrocytes on immune lysis: Anti-T haemolysins. Vox Sanguinis 2011;100:401-8. [DOI: 10.1111/j.1423-0410.2010.01450.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
16 Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, Inward C, Jones C, Pichon B, Reid C, Slack MP, Van't Hoff W, Dillon MJ, Taylor CM, Tullus K. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr 2007;151:140-4. [PMID: 17643764 DOI: 10.1016/j.jpeds.2007.03.055] [Cited by in Crossref: 110] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
17 Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 2004;19:317-21. [PMID: 14714171 DOI: 10.1007/s00467-003-1382-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
18 Agarwal HS, Latifi SQ. Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine. Pathogens 2021;10:727. [PMID: 34207609 DOI: 10.3390/pathogens10060727] [Reference Citation Analysis]
19 British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122:10-23. [PMID: 12823341 DOI: 10.1046/j.1365-2141.2003.04468.x] [Cited by in Crossref: 430] [Cited by in F6Publishing: 344] [Article Influence: 22.6] [Reference Citation Analysis]
20 Bitzan M, AlKandari O, Whittemore B, Yin XL. Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic concept. Int J Med Microbiol 2018;308:1096-104. [PMID: 30177469 DOI: 10.1016/j.ijmm.2018.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 New HV, Berryman J, Bolton-maggs PHB, Cantwell C, Chalmers EA, Davies T, Gottstein R, Kelleher A, Kumar S, Morley SL, Stanworth SJ; the British Committee for Standards in Haematology. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol 2016;175:784-828. [DOI: 10.1111/bjh.14233] [Cited by in Crossref: 122] [Cited by in F6Publishing: 95] [Article Influence: 20.3] [Reference Citation Analysis]
22 . Polyagglutination and Cryptantigens. Human Blood Groups. Oxford: Wiley-Blackwell; 2013. pp. 515-23. [DOI: 10.1002/9781118493595.ch33] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Walsh PR, Johnson S. Treatment and management of children with haemolytic uraemic syndrome. Arch Dis Child 2018;103:285-91. [PMID: 28899876 DOI: 10.1136/archdischild-2016-311377] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
24 Girelli G, Antoncecchi S, Casadei AM, Del Vecchio A, Isernia P, Motta M, Regoli D, Romagnoli C, Tripodi G, Velati C. Recommendations for transfusion therapy in neonatology. Blood Transfus 2015;13:484-97. [PMID: 26445308 DOI: 10.2450/2015.0113-15] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
25 Jacquot C, Pary PP, Babu V, Belay E, Mo YD, Webb JL, Luban NLC, Delaney M. Erythrocyte T-antigen activation in children: Patient characteristics and the hemolytic risk of transfusion. Pediatr Blood Cancer 2021;68:e29082. [PMID: 33900685 DOI: 10.1002/pbc.29082] [Reference Citation Analysis]
26 Moh-klaren J, Bodivit G, Jugie M, Chadebech P, Chevret L, Mokhtari M, Chamillard X, Gallon P, Tissières P, Bierling P, Djoudi R, Pirenne F, Burin-des-roziers N. Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection, and red blood cell T-polyagglutination: T-ANTIGEN ACTIVATION AND HEMOLYSIS IN NEC. Transfusion 2017;57:2571-7. [DOI: 10.1111/trf.14196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
27 O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11-28. [PMID: 15198728 DOI: 10.1111/j.1365-2141.2004.04972.x] [Cited by in Crossref: 574] [Cited by in F6Publishing: 465] [Article Influence: 31.9] [Reference Citation Analysis]